default author photo

Yusen Dai

Luye Pharma Group Ltd.

SCHOLARLY PAPERS

1

DOWNLOADS

81

TOTAL CITATIONS

1

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

A Novel Scaffold Long-Acting Selective Estrogen Receptor Antagonist and Degrader with Superior Preclinical Profile Against Er+ Breast Cancer

Number of pages: 49 Posted: 05 Sep 2023
Bingsi Wang, Mingxu Ma, Yusen Dai, Pengfei Yu, Liang Ye, Wenyan Wang, Chunjie Sha, Huijie Yang, Yingjie Yang, Yunjing Zhu, Lin Dong, Shujuan Wei, Linlin Wang, Jingwei Tian and Hongbo Wang
Yantai University, Yantai University, Luye Pharma Group Ltd., Binzhou Medical University, Binzhou Medical University, Yantai University, Luye Pharma Group Ltd., Luye Pharma Group Ltd., Luye Pharma Group Ltd., Luye Pharma Group Ltd., Luye Pharma Group Ltd., Luye Pharma Group Ltd., Shandong University - School of Business, Yantai University - Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong and Yantai University - Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University)
Downloads 81 (809,932)
Citation 1

Abstract:

Loading...

Hydrophobic tags, THC derivatives, Selective estrogen receptor down-regulator/antagonist, Long-acting, Anticancer agents, breast cancer